Whole genome pleiotropy between Alzheimer’s Disease and Autoimmune Disorders (21806)
We aimed to determine pleiotropic risk genes mediating Alzheimer's (AD) and 7 autoimmune diseases using next generation multi-trait analysis tool, PLEIO.
We analysed the largest and most recent GWAS from AD in combination with 7 autoimmune diseases including Inflammatory Bowel Disease (IBD), Crohn's Disease (CD), Ulcerative Colitis (UC), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), Type 1 Diabetes (T1D) and Vitiligo (Vi). We used the novel tool PLEIO to evaluate the influence of AD risk mutations in a multi-trait analysis of well-established autoimmune diseases. Unlike traditional meta analysis, PLEIO factors in the complex genetic architecture of traits such as correlations and heritabilities, and utilises a joint likelihood framework to increase power to detect pleiotropic single nucleotide polymorphisms (SNPs).
Autoimmune disease showed a higher percentage SNP heritability (H2 = 0.14 - 0.4) compared to AD (H2 = 0.07). Genetically, AD was positively correlated with CD, IBD, SLE, UC and Vi (rg = 0.002 - 0.01) and negatively correlated with RA and T1D (rg =-0.09 - -0.1). Pleiotropic analysis of disease associated loci for AD and 7 autoimmune diseases uncovered 40 novel SNPs, 29 of which are located on protein coding regions. Functional annotation identified 7 SNPs as expression quantitative trait loci (eQTLs) significantly associated with changes of expression for 10 genes. Gene prioritisation analysis identified 9 of the 10 genes as likely causal for disease outcomes.
Our study presents the largest pleiotropy study investigating the shared genetic etiology of AD and autoimmune disease with a newly developed analysis method.